The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial
Cindy Sharon Ortiz, Diana Hernández, Cesar Trujillo, David Calderón, P Gonzalez Esqueda, Flavio Calva, Arcadio Betancourt, Miriam Ramírez, Graciela Cervantes, Miguel Abel Souto, Juan G. Celis, Luis R. Nolazco, Alejandro Olmos
Abstract
This is a paired prospective comparative cohort study with 58 patients, in order to analyze the clinical LD-WLI in patients with moderate or severe COVID19 pneumonia. The results of this study show that the Radiotherapy could be an option to improve the clinical response for patients with COVID-19.
Topics & Concepts
MedicinePneumoniaCoronavirus disease 2019 (COVID-19)Clinical trialProspective cohort studyLungSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cohort studyCohort2019-20 coronavirus outbreakInternal medicinePathologyOutbreakDiseaseInfectious disease (medical specialty)Effects of Radiation ExposureUltrasound and Hyperthermia ApplicationsCOVID-19 and healthcare impacts